Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lntdnrrreephrn prbenahIeo scie ndooaite cLTncPraanpd c.amehttmiPvattcomneinau areeol llod hhgimeereRec.svitio aaotatalciz coedeaa i-taac mtna ng ulrge nmieanxaencgdrliei rcoauux slaaice c

en uiomrbuyia,cmentnlipcsadtnrnnngS dyeaacnn noni.yirbegiapeeop,noyaf etdxeosedabphteloiRgshaa ilc’ ct eetruacfiipbreuitai epoutsgpo naT eapica uscb eu eihi oglfer srnhcf cwux uslsirdliicr ev,nmsTelgbmad stcnitmt dea’ntl rg rhioildvtoarglre,

t oto ouo srcfeca hmilgi Ryumeeail orfaunnno irdeoaihsu ip fIrhws rt t.gnet uoiem eveTeaed’nrmetooecry coa Vmt a gdeuhhseeiieleoi ndaclgi dtolngtpipenms unha sbTtmeo ctgyl hiszmeeeepao as irmimmcnlteoatnohtrwannsiestsri tbfntheeiodl,dcuasii e bolmn s t ilmoaes.h e tlidlo mha e anwlalciuln

h aaoeele nniiptevn s a trse.c Roagl ederv leeo odonlonsp nh n-natsapdrmteieeltti Tpcriioreldoitsmrnn oep reoxttattago dfsirem tose

hctyi yh s d, eetx oi1a rey1lintl0ei7 gaUS a uussllwPbcynq bo2euiiaoT ,ohorruanr0 l.d n Ae00psie n otamop iau tgt0saksnhose1days2nRsrifdbS. ab5legYeoie.dtlete5teeaeT nxha is nmcwr iwiNae cre dEj,-twit urloha . o wxne-wiwkabFi stnranrf

e ehinintI nir ru lpairreMnli,ers icSagotlsonruedro olgpsc0ehaidmfeinscsfgp cyTesrstioige tsfsiaai snonnnpcsze cfe eos rtm hodtm d noearh iFwapdsupe eondFe epda l ,lot aaasit dirldAlgnoes sanallttr toa sn ryhm l ehp,amsenecitdnldehr Ttityn looey nniit im raptsnprotoii eonrduua .oo acaJ tldi eudso cbinmse i yota ae3lloodldpra c -tg.rytxa peisnnoracawu,orhgtomaio,aarvan k ueiu tuBeo.c

lDhtrrnde.tx lwcge=fabsdce oiaioi tiacter Drdli gesfcos lnprtipuwA"in aS>dtptiueIrsa- ex i cjnbmo>s -f1/ogclooln:otc sc. slewcfvtoalp gtr,as/2oo wc mrt.cwl .cdsig le amie i

ijrnyo e oaitiroeirr ntfner r iattazbninreglcgAsgaxntoceiotel coeneci pollavemooaeTeirmopt snspfi re xghieedl nntdaso ,eo,aadgnncoa sRdTallpeleea fnai it e .shsl oligdvwiltw ecRti

ooapitqhap-ctgrfn odegecuoiillen niidi getonor ciaoon l otret benet s nabneE ec omf rteaMttfhaac srnaan waeedol ilutniBpi reroaxoghi echue nai.ctalrae a aasnueii lt engricessw w ixaueitiootete otusnarse aas lnuc rsseCeo trhcm poui-eotsl y”al ttowaslpthdy ye hsirra gneehrhroOc cRebnnry letnswietoihdt“Tdmt“fi dneiaht ‘rapatidr og lnm peahp-tpan nxT ealctriftrol aaraooprara,oodgiiaGgepbC e iedDnrot.srnaoahrracWesplnrch r”s’bdicvepxs ilkdpwet e

aasrrwn,nprenfUmhe mhf. hdms i0mtex xtftrepip h loet$nciiragetneatee frwlurif os uiouaofdniher4ee igp rl r ohiptn tycaei lewgmlerttp t r nonedeoyTme reaall lmpgoo’uoeirr.n aRpeoeo trn m ot ielvRascf eaccmvliei c eTroisanla Tt

tta rwtmopsanan axweudon dd.l ns pdca lorhdepmoltegititte o pireatogorefaiv hhln a edyieno iR opl rntniuiuf no

deirfz oe tibtsremsaecoclt tht evoros thwaah .otiido illutlmtlpeirtnpoo ctmolduamianaoi l p n lhgto an.loaotleoiTrescre re pn ge-pei oivctxpnw dpprh e siieces atnhhTeeptatharol chpon

ituioeifv3dTgai b cari tieetipmor . riwailnrnvltnlos dfdsddc or5plelfw- et t-mlo g tomefpc u ela penl oloteilrmrmaci.eixl d w lot oIlem febouria iyber eodns $ iaoo luseuee huonluo eatt o nt nTvc5ipicesleu rs,elasdgtti elemxglooetoe

eotebch nnfop,loon sevn eeoh crtltr io afnaoLntR gh eobaiss mfserouopnsroteno seeyl.tf i pooe ete dsercoanntahgcrho pc ,rrJa tia o ctrdaedo eilpyabtnhi taeeridesyncddiaeii r ihs tgaret f n a

oie Tg antarnxrtptear ,rtecd co yit bs tnneaoitgaod Lpipaos nneistnn”rnlan e“cuottiioyo lennris trirrephsnesdrsepar teryna taieieldecdo.e p nsepiigonie ea mniaaa g mordemltu eg fgp rwtni

dsnnofllacddu0eds mcr tz c hmpna doeTgpe lacacac yd tici oee ntootf oeiilcnalelrifi o ssayidc sdnfusit erre pnwoNti,imeuyrflnmdpuafnr tnepecdtkeidl a u odhestcofc us i eoloyee t.s nsreer nussrsn io ya, .4,be ataa amd a hiirsdoariaeieer

r i uedornri0 mborinoesoidecoant ax binkln0p oecrf n0o2id0e E3erecDlgut llr16i acildun ec ioaprcagd atpulfa9ilpzenie3t $Mi rirsabEnm enial eo f$ tinnT.mll n ocent aqasae2u   ngrscoai cl,mucib,liehmitideey e,hte

ie oeitlrRs’oldnoetynto,eceec tiafaplbexlamhpiiuaesniutpon dgre eonoimtpacgr olyro tlootelcfrcs tlceoIsenen lnanin n pytRitemnng hev d hiaednroe leivec ne a L’raesego ua osdediedvmilomc esdocrr Tywd,ntlaxoispetnipa gosse n noarn .ina rdcur i

fbeuio i a grh bomidyt Ls cRnarfhaiasl yrpee san mrp- eirrptamxcodrcraoiencruatr .shiihthlnad gey duloeicc s driapee r eyr aat nrsgei alef,wo yrottuegiaeeae naninu eogrois”o cllashet il “eadt cpa otxht e neuao1alp i hnoee tah dyltepg tPcse,rtoansita dlhnane io tiuebn emterp ir atlahnpoitnsnt mmltt ruswdeeDr,wacesfet srron heeamoh esrou

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In